Adaptimmune Therapeutics Plc (ADAPY)
0.0151
0.00 (0.00%)
USD |
OTCM |
Mar 03, 16:00
Adaptimmune Therapeutics EPS Diluted (Quarterly) : -0.1163 for June 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Silence Therapeutics Plc | -0.1479 |
| Biodexa Pharmaceuticals Plc | -- |
| Oxford Biomedica Plc | -- |
| NuCana Plc | -0.1348 |
| Autolus Therapeutics Plc | -0.2954 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.72M |
| Revenue (Quarterly) | 13.85M |
| Total Expenses (Quarterly) | 44.56M |
| Enterprise Value | 26.62M |
| Gross Profit Margin (Quarterly) | 63.37% |
| Profit Margin (Quarterly) | -221.8% |
| Earnings Yield | -4.36K% |
| Normalized Earnings Yield | -4030.46 |